Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STAT3 | P40763 | 8/20 | 0.76 |
| ▸ | GCGR | P47871 | 6/20 | 0.49 |
| ▸ | GIPR | P48546 | 5/20 | 0.47 |
| ▸ | PTGES | O14684 | 3/20 | 0.46 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.43 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17083303 | 0.92 | STAT3 (0.79) | STAT3GCGRGIPRPTGESALOX5 | |
| SCHEMBL17083301 | 0.91 | STAT3 (0.83) | STAT3GCGRGIPRPTGESALOX5 | |
| SCHEMBL17083302 | 0.90 | STAT3 (0.79) | STAT3GCGRPTGESALOX5 | |
| SCHEMBL15668402 | 0.89 | STAT3 (0.75) | STAT3 | |
| SCHEMBL15668215 | 0.89 | STAT3 (0.84) | STAT3 | |
| SCHEMBL25403432 | 0.86 | STAT3 (0.76) | STAT3GCGRGIPRPTGESALOX5 | |
| SCHEMBL17076888 | 0.86 | STAT3 (1.00) | STAT3GCGRGIPRPTGESALOX5 | |
| Phosphine SCHEMBL20327798 | 0.86 | STAT3 (0.75) | STAT3GCGRGIPRPTGESALOX5 | |
| SCHEMBL17076921 | 0.86 | STAT3 (1.00) | STAT3GCGRGIPRPTGESALOX5 | |
| SCHEMBL17083305 | 0.85 | STAT3 (0.79) | STAT3GCGRGIPRPTGESALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230212568-A1 | MICRORNA-MEDIATED METHODS FOR REJUVENATING CNS GLIAL POPULATIONS | UNIVERSITY OF ROCHESTER | 2023-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230212568-A1 | MICRORNA-MEDIATED METHODS FOR REJUVENATING CNS GLIAL POPULATIONS | MYT1, STAT3, MYC | STAT3 2/4885GCGR 2792/4885GIPR 4156/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.